NetraMark - About the company
NetraMark is a public company based in Toronto (Canada), founded in 2015 by Richard Brooks,. It operates as an AI-assisted platform for drug discovery and development. NetraMark has raised an undisclosed amount in funding. The company has 303 active competitors, including 55 funded and 42 that have exited. Its top competitors include companies like Medidata, IQVIA and Verily.
Company Details
NetraMark provides an AI-assisted platform for drug discovery and development. The platform utilizes machine learning technology for the prediction of the lead candidates. The company claims to provide ALS predictions, responses to anti-depressant drugs, and predict placebo responses.
- Website
- www.netramark.com/
- Social
- Email ID
- *****@netramark.com
- Phone Number
- +1 **********
Key Metrics
Founded Year
2015
Location
Toronto, Canada
Stage
Public
Latest Funding Round
Ranked
22nd among 303 active competitors
Employee Count
26 as on May 31, 2026
Exit Details
Public
NetraMark's IPO details
NetraMark got listed on Jun 07, 2021.
Click here to take a look at NetraMark's IPO in detail
Sign up to download NetraMark's company profile
NetraMark's funding and investors
NetraMark has raised funding over 6 rounds. Its first funding round was on Jun 21, 2017. NetraMark has 3 institutional investors.
Here is the list of recent funding rounds of NetraMark:
Filter this list
Filter this listDate of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Jan 13, 2026 | 2205729 | Post IPO | 8808337 | 2469044 | 8077426 | 7595899 |
Dec 16, 2025 | 3019475 | Grant (prize money) | 5569835 | 7998107 | 5349477 | 1553690 |
Sep 19, 2023 | 2950671 | Post IPO | 7406592 | 1889444 | 8888252 | 7942377 |
Access funding benchmarks and valuations. Sign up today!View details of NetraMark's funding rounds and investors
NetraMark's founders and board of directors
Founder? Claim ProfileThe founders of NetraMark is Richard Brooks,.
Here are the details of NetraMark's key team members:
- Richard Brooks,: Co-Founder & COO of NetraMark.
View details of NetraMark's Founder profiles and Board Members
NetraMark's employee count trend
NetraMark has 26 employees as of May 26. Here is NetraMark's employee count trend over the years:
Uncover NetraMark's growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
NetraMark's Competitors and alternates
Top competitors of NetraMark include Medidata, IQVIA and Verily. Here is the list of Top 10 competitors of NetraMark, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st |  Medidata 1999, New York City (United States), Acquired | AI-based clinical trial management software for researchers | $41.5M | 86/100 | |
2nd |  IQVIA 1982, Durham (United States), Public | Provider of clinical research and commercialization solutions for healthcare | $1.74M | 80/100 | |
3rd |  Verily 2015, Dallas (United States), Series D | Developer of precision health platforms and solutions using artificial intelligence | $2.8B | 79/100 | |
4th |  Tempus 2015, Chicago (United States), Public | Developer of genomic testing and artificial intelligence tools for medicine | $1.05B | 74/100 | |
5th |  Signant Health 2000, Plymouth Meeting (United States), Acquired | Provider of a software solution for clinical trial management | $3.4M | 72/100 | |
6th |  Science 37 2014, Los Angeles (United States), Acquired | Provider of a suite solution for clinical trials for researchers | $106M | 70/100 | |
7th | Viz.ai 2016, San Francisco (United States), Series D | Developer of an AI-powered platform for care coordination and disease detection | $252M | 69/100 | |
8th |  TriNetX 2013, Cambridge (United States), Acquired | Provider of clinical trial management software for researchers and professionals | $102M | 66/100 | |
9th | _1556172390155.png?devicePixelRatio=2&height=30&width=30){kind=logo} BrightInsight 2017, San Jose (United States), Series C | Provider of digital health solutions for clinical trials | $179M | 64/100 | |
10th | Wcg Clinical 2012, Princeton (United States), Acquired | CRO offering regulatory and ethical review services for clinical research | - | 64/100 | |
22nd | AI-assisted platform for drug discovery and development | - | 57/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on NetraMark's competitors? Click here to see the top ones
NetraMark's Investments and acquisitions
NetraMark has made no investments or acquisitions yet.
News related to NetraMark
Filter this listMedia has covered NetraMark for a total of 27 events in the last 1 year, 15 of them have been about company updates and 4 about people movement.
•
•
•
•
NetraMark Signs Contract With Global Biopharmaceutical Company to Analyze Phase 2 Depression Trial DataGlobeNewswire•Mar 11, 2026•NetraMark,
•
NetraMark Closes Final Tranche of $3.5 Million Private PlacementBusiness Insider•Feb 19, 2026•NetraMark
•
•
NetraMark Enhances Board Accessibility by Appointing Lawrence Guy as DirectorGlobeNewswire•Jan 29, 2026•NetraMark
•
•
•
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about NetraMark
Explore our recently published companies
- In-Dapt - Dallas based, Unfunded company
- Vijverberg - Unfunded company
- Cuisines Madec - Lanhouarneau based, 2013 founded, Unfunded company
- sts Bauberatung - Germany based, Unfunded company
- Edandp - Unfunded company
- Planungsbüro Robitsek GmbH & Co. KG - Germany based, 2008 founded, Unfunded company
